APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

NTA-IDA Chelating Ligands

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global NTA-IDA Chelating Ligands Market Outlook and Growth Opportunities 2026

13 August 2026194 pages

Choose your research edition.

Industry ResearchNTA-IDA Chelating Ligands Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal NTA-IDA Chelating Ligands Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal NTA-IDA Chelating Ligands Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal NTA-IDA Chelating Ligands Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal NTA-IDA Chelating Ligands Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global NTA-IDA Chelating Ligands market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for NTA-IDA Chelating Ligands is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for NTA-IDA Chelating Ligands is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for NTA-IDA Chelating Ligands is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the NTA-IDA Chelating Ligands market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the NTA-IDA Chelating Ligands market include Merck, Bio-Rad, Bio-Works, Macherey-Nagel, Cube Biotech, G-Biosciences, GenScript, BestChrom and NanoMicro, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global NTA-IDA Chelating Ligands market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of NTA-IDA Chelating Ligands and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents NTA-IDA Chelating Ligands sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the NTA-IDA Chelating Ligands market size, projected growth trends, production technologies, key applications, and end-use industries.

NTA-IDA Chelating Ligands Segment by Company

Merck

Bio-Rad

Bio-Works

Macherey-Nagel

Cube Biotech

G-Biosciences

GenScript

BestChrom

NanoMicro

Duoning Biotech

Smart-Lifesciences

Resindion

Cytiva

Thermo Fisher Scientific

Qiagen

NTA-IDA Chelating Ligands Segment by Type

NTA Chelating Ligand

IDA Chelating Ligand

NTA and IDA Screening Set

Other IMAC Chelating Ligand

NTA-IDA Chelating Ligands Segment by Application

His-Tagged Protein Purification

Process Development and Scale-Up

Metal-Binding Protein Enrichment

Phosphopeptide Enrichment

Metal Ion Removal

Other Research Use

NTA-IDA Chelating Ligands Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global NTA-IDA Chelating Ligands status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions NTA-IDA Chelating Ligands market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify NTA-IDA Chelating Ligands significant trends, drivers, influence factors in global and regions.

6. To analyze NTA-IDA Chelating Ligands competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NTA-IDA Chelating Ligands market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of NTA-IDA Chelating Ligands and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NTA-IDA Chelating Ligands.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the NTA-IDA Chelating Ligands market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global NTA-IDA Chelating Ligands industry.

Chapter 3: Detailed analysis of NTA-IDA Chelating Ligands manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of NTA-IDA Chelating Ligands in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of NTA-IDA Chelating Ligands in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. NTA-IDA Chelating Ligands Industry Trends Table 2. NTA-IDA Chelating Ligands Industry Drivers Table 3. NTA-IDA Chelating Ligands Industry Opportunities and Challenges Table 4. NTA-IDA Chelating Ligands Industry Restraints Table 5. Global NTA-IDA Chelating Ligands Revenue by Company (US$ Million) & (2021-2026) Table 6. Global NTA-IDA Chelating Ligands Revenue Share by Company (2021-2026) Table 7. Global NTA-IDA Chelating Ligands Sales Volume by Company (t) & (2021-2026) Table 8. Global NTA-IDA Chelating Ligands Sales Volume Share by Company (2021-2026) Table 9. Global NTA-IDA Chelating Ligands Average Price (USD/t) of Company (2021-2026) Table 10. Global NTA-IDA Chelating Ligands Company Ranking, (2024-2026) & (USD Million) Table 11. Global NTA-IDA Chelating Ligands Key Company Manufacturing Base & Headquarters Table 12. Global NTA-IDA Chelating Ligands Company, Product Type & Application Table 13. Global NTA-IDA Chelating Ligands Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global NTA-IDA Chelating Ligands by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of NTA Chelating Ligand Table 18. Significant Companies of IDA Chelating Ligand Table 19. Significant Companies of NTA and IDA Screening Set Table 20. Significant Companies of Other IMAC Chelating Ligand Table 21. Global NTA-IDA Chelating Ligands Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 22. Global NTA-IDA Chelating Ligands Sales Volume by Type (2021-2026) & (t) Table 23. Global NTA-IDA Chelating Ligands Sales Volume by Type (2027-2032) & (t) Table 24. Global NTA-IDA Chelating Ligands Sales Volume Share by Type (2021-2026) Table 25. Global NTA-IDA Chelating Ligands Sales Volume Share by Type (2027-2032) Table 26. Global NTA-IDA Chelating Ligands Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global NTA-IDA Chelating Ligands Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global NTA-IDA Chelating Ligands Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global NTA-IDA Chelating Ligands Sales Value Share by Type (2021-2026) Table 30. Global NTA-IDA Chelating Ligands Sales Value Share by Type (2027-2032) Table 31. Significant Companies of His-Tagged Protein Purification Table 32. Significant Companies of Process Development and Scale-Up Table 33. Significant Companies of Metal-Binding Protein Enrichment Table 34. Significant Companies of Phosphopeptide Enrichment Table 35. Significant Companies of Metal Ion Removal Table 36. Significant Companies of Other Research Use Table 37. Global NTA-IDA Chelating Ligands Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 38. Global NTA-IDA Chelating Ligands Sales Volume by Application (2021-2026) & (t) Table 39. Global NTA-IDA Chelating Ligands Sales Volume by Application (2027-2032) & (t) Table 40. Global NTA-IDA Chelating Ligands Sales Volume Share by Application (2021-2026) Table 41. Global NTA-IDA Chelating Ligands Sales Volume Share by Application (2027-2032) Table 42. Global NTA-IDA Chelating Ligands Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global NTA-IDA Chelating Ligands Sales Value by Application (2021-2026) & (US$ Million) Table 44. Global NTA-IDA Chelating Ligands Sales Value by Application (2027-2032) & (US$ Million) Table 45. Global NTA-IDA Chelating Ligands Sales Value Share by Application (2021-2026) Table 46. Global NTA-IDA Chelating Ligands Sales Value Share by Application (2027-2032) Table 47. Global NTA-IDA Chelating Ligands Sales by Region: 2021 VS 2025 VS 2032 (t) Table 48. Global NTA-IDA Chelating Ligands Sales by Region (2021-2026) & (t) Table 49. Global NTA-IDA Chelating Ligands Sales Market Share by Region (2021-2026) Table 50. Global NTA-IDA Chelating Ligands Sales by Region (2027-2032) & (t) Table 51. Global NTA-IDA Chelating Ligands Sales Market Share by Region (2027-2032) Table 52. Global NTA-IDA Chelating Ligands Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global NTA-IDA Chelating Ligands Sales Value by Region (2021-2026) & (US$ Million) Table 54. Global NTA-IDA Chelating Ligands Sales Value Share by Region (2021-2026) Table 55. Global NTA-IDA Chelating Ligands Sales Value by Region (2027-2032) & (US$ Million) Table 56. Global NTA-IDA Chelating Ligands Sales Value Share by Region (2027-2032) Table 57. Global NTA-IDA Chelating Ligands Market Average Price (USD/t) by Region (2021-2026) Table 58. Global NTA-IDA Chelating Ligands Market Average Price (USD/t) by Region (2027-2032) Table 59. Global NTA-IDA Chelating Ligands Sales by Country: 2021 VS 2025 VS 2032 (t) Table 60. Global NTA-IDA Chelating Ligands Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global NTA-IDA Chelating Ligands Sales by Country (2021-2026) & (t) Table 62. Global NTA-IDA Chelating Ligands Sales Market Share by Country (2021-2026) Table 63. Global NTA-IDA Chelating Ligands Sales by Country (2027-2032) & (t) Table 64. Global NTA-IDA Chelating Ligands Sales Market Share by Country (2027-2032) Table 65. Global NTA-IDA Chelating Ligands Sales Value by Country (2021-2026) & (US$ Million) Table 66. Global NTA-IDA Chelating Ligands Sales Value Market Share by Country (2021-2026) Table 67. Global NTA-IDA Chelating Ligands Sales Value by Country (2027-2032) & (US$ Million) Table 68. Global NTA-IDA Chelating Ligands Sales Value Market Share by Country (2027-2032) Table 69. Merck Company Information Table 70. Merck Business Overview Table 71. Merck NTA-IDA Chelating Ligands Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 72. Merck NTA-IDA Chelating Ligands Product Portfolio Table 73. Merck Recent Development Table 74. Bio-Rad Company Information Table 75. Bio-Rad Business Overview Table 76. Bio-Rad NTA-IDA Chelating Ligands Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 77. Bio-Rad NTA-IDA Chelating Ligands Product Portfolio Table 78. Bio-Rad Recent Development Table 79. Bio-Works Company Information Table 80. Bio-Works Business Overview Table 81. Bio-Works NTA-IDA Chelating Ligands Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 82. Bio-Works NTA-IDA Chelating Ligands Product Portfolio Table 83. Bio-Works Recent Development Table 84. Macherey-Nagel Company Information Table 85. Macherey-Nagel Business Overview Table 86. Macherey-Nagel NTA-IDA Chelating Ligands Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 87. Macherey-Nagel NTA-IDA Chelating Ligands Product Portfolio Table 88. Macherey-Nagel Recent Development Table 89. Cube Biotech Company Information Table 90. Cube Biotech Business Overview Table 91. Cube Biotech NTA-IDA Chelating Ligands Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 92. Cube Biotech NTA-IDA Chelating Ligands Product Portfolio Table 93. Cube Biotech Recent Development Table 94. G-Biosciences Company Information Table 95. G-Biosciences Business Overview Table 96. G-Biosciences NTA-IDA Chelating Ligands Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 97. G-Biosciences NTA-IDA Chelating Ligands Product Portfolio Table 98. G-Biosciences Recent Development Table 99. GenScript Company Information Table 100. GenScript Business Overview Table 101. GenScript NTA-IDA Chelating Ligands Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 102. GenScript NTA-IDA Chelating Ligands Product Portfolio Table 103. GenScript Recent Development Table 104. BestChrom Company Information Table 105. BestChrom Business Overview Table 106. BestChrom NTA-IDA Chelating Ligands Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 107. BestChrom NTA-IDA Chelating Ligands Product Portfolio Table 108. BestChrom Recent Development Table 109. NanoMicro Company Information Table 110. NanoMicro Business Overview Table 111. NanoMicro NTA-IDA Chelating Ligands Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 112. NanoMicro NTA-IDA Chelating Ligands Product Portfolio Table 113. NanoMicro Recent Development Table 114. Duoning Biotech Company Information Table 115. Duoning Biotech Business Overview Table 116. Duoning Biotech NTA-IDA Chelating Ligands Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 117. Duoning Biotech NTA-IDA Chelating Ligands Product Portfolio Table 118. Duoning Biotech Recent Development Table 119. Smart-Lifesciences Company Information Table 120. Smart-Lifesciences Business Overview Table 121. Smart-Lifesciences NTA-IDA Chelating Ligands Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 122. Smart-Lifesciences NTA-IDA Chelating Ligands Product Portfolio Table 123. Smart-Lifesciences Recent Development Table 124. Resindion Company Information Table 125. Resindion Business Overview Table 126. Resindion NTA-IDA Chelating Ligands Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 127. Resindion NTA-IDA Chelating Ligands Product Portfolio Table 128. Resindion Recent Development Table 129. Cytiva Company Information Table 130. Cytiva Business Overview Table 131. Cytiva NTA-IDA Chelating Ligands Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 132. Cytiva NTA-IDA Chelating Ligands Product Portfolio Table 133. Cytiva Recent Development Table 134. Thermo Fisher Scientific Company Information Table 135. Thermo Fisher Scientific Business Overview Table 136. Thermo Fisher Scientific NTA-IDA Chelating Ligands Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 137. Thermo Fisher Scientific NTA-IDA Chelating Ligands Product Portfolio Table 138. Thermo Fisher Scientific Recent Development Table 139. Qiagen Company Information Table 140. Qiagen Business Overview Table 141. Qiagen NTA-IDA Chelating Ligands Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 142. Qiagen NTA-IDA Chelating Ligands Product Portfolio Table 143. Qiagen Recent Development Table 144. Key Raw Materials Table 145. Raw Materials Key Suppliers Table 146. NTA-IDA Chelating Ligands Distributors List Table 147. NTA-IDA Chelating Ligands Customers List Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources Table 151. Primary Sources List of Figures Figure 1. NTA-IDA Chelating Ligands Product Image Figure 2. Global NTA-IDA Chelating Ligands Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global NTA-IDA Chelating Ligands Sales Value (2021-2032) & (US$ Million) Figure 4. Global NTA-IDA Chelating Ligands Sales (2021-2032) & (t) Figure 5. Global NTA-IDA Chelating Ligands Sales Average Price (USD/t) & (2021-2032) Figure 6. Global NTA-IDA Chelating Ligands Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. NTA Chelating Ligand Image Figure 10. IDA Chelating Ligand Image Figure 11. NTA and IDA Screening Set Image Figure 12. Other IMAC Chelating Ligand Image Figure 13. Global NTA-IDA Chelating Ligands Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 14. Global NTA-IDA Chelating Ligands Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global NTA-IDA Chelating Ligands Sales Volume Share by Type (2021-2032) Figure 16. Global NTA-IDA Chelating Ligands Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global NTA-IDA Chelating Ligands Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global NTA-IDA Chelating Ligands Sales Value Share by Type (2021-2032) Figure 19. His-Tagged Protein Purification Image Figure 20. Process Development and Scale-Up Image Figure 21. Metal-Binding Protein Enrichment Image Figure 22. Phosphopeptide Enrichment Image Figure 23. Metal Ion Removal Image Figure 24. Other Research Use Image Figure 25. Global NTA-IDA Chelating Ligands Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 26. Global NTA-IDA Chelating Ligands Sales Volume Share 2021 VS 2025 VS 2032 Figure 27. Global NTA-IDA Chelating Ligands Sales Volume Share by Application (2021-2032) Figure 28. Global NTA-IDA Chelating Ligands Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global NTA-IDA Chelating Ligands Sales Value Share 2021 VS 2025 VS 2032 Figure 30. Global NTA-IDA Chelating Ligands Sales Value Share by Application (2021-2032) Figure 31. Global NTA-IDA Chelating Ligands Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 32. Global NTA-IDA Chelating Ligands Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 33. Global NTA-IDA Chelating Ligands Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 34. Global NTA-IDA Chelating Ligands Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 35. North America NTA-IDA Chelating Ligands Sales Value (2021-2032) & (US$ Million) Figure 36. North America NTA-IDA Chelating Ligands Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Europe NTA-IDA Chelating Ligands Sales Value (2021-2032) & (US$ Million) Figure 38. Europe NTA-IDA Chelating Ligands Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Asia-Pacific NTA-IDA Chelating Ligands Sales Value (2021-2032) & (US$ Million) Figure 40. Asia-Pacific NTA-IDA Chelating Ligands Sales Value Share by Country (%), 2025 VS 2032 Figure 41. South America NTA-IDA Chelating Ligands Sales Value (2021-2032) & (US$ Million) Figure 42. South America NTA-IDA Chelating Ligands Sales Value Share by Country (%), 2025 VS 2032 Figure 43. Middle East & Africa NTA-IDA Chelating Ligands Sales Value (2021-2032) & (US$ Million) Figure 44. Middle East & Africa NTA-IDA Chelating Ligands Sales Value Share by Country (%), 2025 VS 2032 Figure 45. USA NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. USA NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. USA NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Canada NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Canada NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Canada NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Mexico NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Mexico NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Mexico NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Germany NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Germany NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Germany NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. France NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. France NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. France NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. U.K. NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. U.K. NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. U.K. NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Italy NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Italy NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Italy NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Spain NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Spain NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Spain NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Russia NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Russia NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Russia NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Netherlands NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Netherlands NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Netherlands NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Nordic Countries NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Nordic Countries NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Nordic Countries NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. China NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. China NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. China NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Japan NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Japan NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Japan NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. South Korea NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. South Korea NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. South Korea NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. India NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. India NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. India NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Australia NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Australia NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Australia NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Southeast Asia NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Southeast Asia NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Southeast Asia NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Brazil NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Brazil NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Brazil NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Argentina NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Argentina NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Argentina NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Chile NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Chile NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Chile NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Colombia NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Colombia NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Colombia NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Peru NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Peru NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Peru NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Saudi Arabia NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Saudi Arabia NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Saudi Arabia NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Israel NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Israel Arabia NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Israel Arabia NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. UAE NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. UAE NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. UAE NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Turkey NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Turkey NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Turkey NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Iran NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Iran NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Iran NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Egypt NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 127. Egypt NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032 & (%) Figure 128. Egypt NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032 & (%) Figure 129. NTA-IDA Chelating Ligands Value Chain Figure 130. Manufacturing Cost Structure Figure 131. NTA-IDA Chelating Ligands Sales Mode & Process Figure 132. Direct Comparison with Distribution Share Figure 133. Distributors Profiles Figure 134. Years Considered Figure 135. Research Process Figure 136. Key Executives Interviewed

Scope & coverage.

Types
  • NTA Chelating Ligand
  • IDA Chelating Ligand
  • NTA and IDA Screening Set
  • Other IMAC Chelating Ligand
Applications
  • His-Tagged Protein Purification
  • Process Development and Scale-Up
  • Metal-Binding Protein Enrichment
  • Phosphopeptide Enrichment
  • Metal Ion Removal
  • Other Research Use
Companies covered
  • Merck
  • Bio-Rad
  • Bio-Works
  • Macherey-Nagel
  • Cube Biotech
  • G-Biosciences
  • GenScript
  • BestChrom
  • NanoMicro
  • Duoning Biotech
  • Smart-Lifesciences
  • Resindion
  • Cytiva
  • Thermo Fisher Scientific
  • Qiagen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global NTA-IDA Chelating Ligands Sales Value (2021-2032)
  4. 1.2.2 Global NTA-IDA Chelating Ligands Sales Volume (2021-2032)
  5. 1.2.3 Global NTA-IDA Chelating Ligands Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 NTA-IDA Chelating Ligands Market Dynamics
  1. 2.1 NTA-IDA Chelating Ligands Industry Trends
  2. 2.2 NTA-IDA Chelating Ligands Industry Drivers
  3. 2.3 NTA-IDA Chelating Ligands Industry Opportunities and Challenges
  4. 2.4 NTA-IDA Chelating Ligands Industry Restraints
3 NTA-IDA Chelating Ligands Market by Company
  1. 3.1 Global NTA-IDA Chelating Ligands Company Revenue Ranking in 2025
  2. 3.2 Global NTA-IDA Chelating Ligands Revenue by Company (2021-2026)
  3. 3.3 Global NTA-IDA Chelating Ligands Sales Volume by Company (2021-2026)
  4. 3.4 Global NTA-IDA Chelating Ligands Average Price by Company (2021-2026)
  5. 3.5 Global NTA-IDA Chelating Ligands Company Ranking (2024-2026)
  6. 3.6 Global NTA-IDA Chelating Ligands Company Manufacturing Base and Headquarters
  7. 3.7 Global NTA-IDA Chelating Ligands Company Product Type and Application
  8. 3.8 Global NTA-IDA Chelating Ligands Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global NTA-IDA Chelating Ligands Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 NTA-IDA Chelating Ligands Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 NTA-IDA Chelating Ligands Market by Type
  1. 4.1 NTA-IDA Chelating Ligands Type Introduction
  2. 4.1.1 NTA Chelating Ligand
  3. 4.1.2 IDA Chelating Ligand
  4. 4.1.3 NTA and IDA Screening Set
  5. 4.1.4 Other IMAC Chelating Ligand
  6. 4.2 Global NTA-IDA Chelating Ligands Sales Volume by Type
  7. 4.2.1 Global NTA-IDA Chelating Ligands Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global NTA-IDA Chelating Ligands Sales Volume by Type (2021-2032)
  9. 4.2.3 Global NTA-IDA Chelating Ligands Sales Volume Share by Type (2021-2032)
  10. 4.3 Global NTA-IDA Chelating Ligands Sales Value by Type
  11. 4.3.1 Global NTA-IDA Chelating Ligands Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global NTA-IDA Chelating Ligands Sales Value by Type (2021-2032)
  13. 4.3.3 Global NTA-IDA Chelating Ligands Sales Value Share by Type (2021-2032)
5 NTA-IDA Chelating Ligands Market by Application
  1. 5.1 NTA-IDA Chelating Ligands Application Introduction
  2. 5.1.1 His-Tagged Protein Purification
  3. 5.1.2 Process Development and Scale-Up
  4. 5.1.3 Metal-Binding Protein Enrichment
  5. 5.1.4 Phosphopeptide Enrichment
  6. 5.1.5 Metal Ion Removal
  7. 5.1.6 Other Research Use
  8. 5.2 Global NTA-IDA Chelating Ligands Sales Volume by Application
  9. 5.2.1 Global NTA-IDA Chelating Ligands Sales Volume by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global NTA-IDA Chelating Ligands Sales Volume by Application (2021-2032)
  11. 5.2.3 Global NTA-IDA Chelating Ligands Sales Volume Share by Application (2021-2032)
  12. 5.3 Global NTA-IDA Chelating Ligands Sales Value by Application
  13. 5.3.1 Global NTA-IDA Chelating Ligands Sales Value by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global NTA-IDA Chelating Ligands Sales Value by Application (2021-2032)
  15. 5.3.3 Global NTA-IDA Chelating Ligands Sales Value Share by Application (2021-2032)
6 NTA-IDA Chelating Ligands Regional Sales and Value Analysis
  1. 6.1 Global NTA-IDA Chelating Ligands Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global NTA-IDA Chelating Ligands Sales by Region (2021-2032)
  3. 6.2.1 Global NTA-IDA Chelating Ligands Sales by Region: 2021-2026
  4. 6.2.2 Global NTA-IDA Chelating Ligands Sales by Region (2027-2032)
  5. 6.3 Global NTA-IDA Chelating Ligands Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global NTA-IDA Chelating Ligands Sales Value by Region (2021-2032)
  7. 6.4.1 Global NTA-IDA Chelating Ligands Sales Value by Region: 2021-2026
  8. 6.4.2 Global NTA-IDA Chelating Ligands Sales Value by Region (2027-2032)
  9. 6.5 Global NTA-IDA Chelating Ligands Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America NTA-IDA Chelating Ligands Sales Value (2021-2032)
  12. 6.6.2 North America NTA-IDA Chelating Ligands Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe NTA-IDA Chelating Ligands Sales Value (2021-2032)
  15. 6.7.2 Europe NTA-IDA Chelating Ligands Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific NTA-IDA Chelating Ligands Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific NTA-IDA Chelating Ligands Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America NTA-IDA Chelating Ligands Sales Value (2021-2032)
  21. 6.9.2 South America NTA-IDA Chelating Ligands Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa NTA-IDA Chelating Ligands Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa NTA-IDA Chelating Ligands Sales Value Share by Country, 2025 VS 2032
7 NTA-IDA Chelating Ligands Country-level Sales and Value Analysis
  1. 7.1 Global NTA-IDA Chelating Ligands Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global NTA-IDA Chelating Ligands Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global NTA-IDA Chelating Ligands Sales by Country (2021-2032)
  4. 7.3.1 Global NTA-IDA Chelating Ligands Sales by Country (2021-2026)
  5. 7.3.2 Global NTA-IDA Chelating Ligands Sales by Country (2027-2032)
  6. 7.4 Global NTA-IDA Chelating Ligands Sales Value by Country (2021-2032)
  7. 7.4.1 Global NTA-IDA Chelating Ligands Sales Value by Country (2021-2026)
  8. 7.4.2 Global NTA-IDA Chelating Ligands Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt NTA-IDA Chelating Ligands Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt NTA-IDA Chelating Ligands Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt NTA-IDA Chelating Ligands Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck
  2. 8.1.1 Merck Company Information
  3. 8.1.2 Merck Business Overview
  4. 8.1.3 Merck NTA-IDA Chelating Ligands Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Merck NTA-IDA Chelating Ligands Product Portfolio
  6. 8.1.5 Merck Recent Developments
  7. 8.2 Bio-Rad
  8. 8.2.1 Bio-Rad Company Information
  9. 8.2.2 Bio-Rad Business Overview
  10. 8.2.3 Bio-Rad NTA-IDA Chelating Ligands Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Bio-Rad NTA-IDA Chelating Ligands Product Portfolio
  12. 8.2.5 Bio-Rad Recent Developments
  13. 8.3 Bio-Works
  14. 8.3.1 Bio-Works Company Information
  15. 8.3.2 Bio-Works Business Overview
  16. 8.3.3 Bio-Works NTA-IDA Chelating Ligands Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Bio-Works NTA-IDA Chelating Ligands Product Portfolio
  18. 8.3.5 Bio-Works Recent Developments
  19. 8.4 Macherey-Nagel
  20. 8.4.1 Macherey-Nagel Company Information
  21. 8.4.2 Macherey-Nagel Business Overview
  22. 8.4.3 Macherey-Nagel NTA-IDA Chelating Ligands Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Macherey-Nagel NTA-IDA Chelating Ligands Product Portfolio
  24. 8.4.5 Macherey-Nagel Recent Developments
  25. 8.5 Cube Biotech
  26. 8.5.1 Cube Biotech Company Information
  27. 8.5.2 Cube Biotech Business Overview
  28. 8.5.3 Cube Biotech NTA-IDA Chelating Ligands Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Cube Biotech NTA-IDA Chelating Ligands Product Portfolio
  30. 8.5.5 Cube Biotech Recent Developments
  31. 8.6 G-Biosciences
  32. 8.6.1 G-Biosciences Company Information
  33. 8.6.2 G-Biosciences Business Overview
  34. 8.6.3 G-Biosciences NTA-IDA Chelating Ligands Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 G-Biosciences NTA-IDA Chelating Ligands Product Portfolio
  36. 8.6.5 G-Biosciences Recent Developments
  37. 8.7 GenScript
  38. 8.7.1 GenScript Company Information
  39. 8.7.2 GenScript Business Overview
  40. 8.7.3 GenScript NTA-IDA Chelating Ligands Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 GenScript NTA-IDA Chelating Ligands Product Portfolio
  42. 8.7.5 GenScript Recent Developments
  43. 8.8 BestChrom
  44. 8.8.1 BestChrom Company Information
  45. 8.8.2 BestChrom Business Overview
  46. 8.8.3 BestChrom NTA-IDA Chelating Ligands Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 BestChrom NTA-IDA Chelating Ligands Product Portfolio
  48. 8.8.5 BestChrom Recent Developments
  49. 8.9 NanoMicro
  50. 8.9.1 NanoMicro Company Information
  51. 8.9.2 NanoMicro Business Overview
  52. 8.9.3 NanoMicro NTA-IDA Chelating Ligands Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 NanoMicro NTA-IDA Chelating Ligands Product Portfolio
  54. 8.9.5 NanoMicro Recent Developments
  55. 8.10 Duoning Biotech
  56. 8.10.1 Duoning Biotech Company Information
  57. 8.10.2 Duoning Biotech Business Overview
  58. 8.10.3 Duoning Biotech NTA-IDA Chelating Ligands Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Duoning Biotech NTA-IDA Chelating Ligands Product Portfolio
  60. 8.10.5 Duoning Biotech Recent Developments
  61. 8.11 Smart-Lifesciences
  62. 8.11.1 Smart-Lifesciences Company Information
  63. 8.11.2 Smart-Lifesciences Business Overview
  64. 8.11.3 Smart-Lifesciences NTA-IDA Chelating Ligands Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Smart-Lifesciences NTA-IDA Chelating Ligands Product Portfolio
  66. 8.11.5 Smart-Lifesciences Recent Developments
  67. 8.12 Resindion
  68. 8.12.1 Resindion Company Information
  69. 8.12.2 Resindion Business Overview
  70. 8.12.3 Resindion NTA-IDA Chelating Ligands Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Resindion NTA-IDA Chelating Ligands Product Portfolio
  72. 8.12.5 Resindion Recent Developments
  73. 8.13 Cytiva
  74. 8.13.1 Cytiva Company Information
  75. 8.13.2 Cytiva Business Overview
  76. 8.13.3 Cytiva NTA-IDA Chelating Ligands Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Cytiva NTA-IDA Chelating Ligands Product Portfolio
  78. 8.13.5 Cytiva Recent Developments
  79. 8.14 Thermo Fisher Scientific
  80. 8.14.1 Thermo Fisher Scientific Company Information
  81. 8.14.2 Thermo Fisher Scientific Business Overview
  82. 8.14.3 Thermo Fisher Scientific NTA-IDA Chelating Ligands Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Thermo Fisher Scientific NTA-IDA Chelating Ligands Product Portfolio
  84. 8.14.5 Thermo Fisher Scientific Recent Developments
  85. 8.15 Qiagen
  86. 8.15.1 Qiagen Company Information
  87. 8.15.2 Qiagen Business Overview
  88. 8.15.3 Qiagen NTA-IDA Chelating Ligands Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Qiagen NTA-IDA Chelating Ligands Product Portfolio
  90. 8.15.5 Qiagen Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 NTA-IDA Chelating Ligands Value Chain Analysis
  2. 9.1.1 NTA-IDA Chelating Ligands Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 NTA-IDA Chelating Ligands Sales Mode & Process
  6. 9.2 NTA-IDA Chelating Ligands Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 NTA-IDA Chelating Ligands Distributors
  9. 9.2.3 NTA-IDA Chelating Ligands Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst